Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and...

59
1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a 2-oxo-C-allyl iminosugar Quentin Foucart, a Yuna Shimadate, b Jérôme Marrot, c Atsushi Kato,* b Jérôme Désiré,* a Yves Blériot a * a Université de Poitiers, UMR CNRS 7285, IC2MP, Équipe Synthèse organique, Groupe Glycochimie, 4 Rue Michel Brunet, 86073 Poitiers Cedex 9, France. b Department of Hospital Pharmacy, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. c Institut Lavoisier de Versailles, UMR CNRS 8180, Université de Versailles, 45 Avenue des Etats-Unis, 78035 Versailles Cedex, France. Copies of 1 H and 13 C NMR spectra p 2-54 Cristallographic data for compound 10b p 55-59 Electronic Supplementary Material (ESI) for Organic & Biomolecular Chemistry. This journal is © The Royal Society of Chemistry 2019

Transcript of Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and...

Page 1: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

1

Electronic Supplementary Information

Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a 2-oxo-C-allyl iminosugar

Quentin Foucart,a Yuna Shimadate,b Jérôme Marrot,c Atsushi Kato,*b Jérôme Désiré,*a Yves Blériota*

a Université de Poitiers, UMR CNRS 7285, IC2MP, Équipe Synthèse organique, Groupe Glycochimie, 4 Rue Michel Brunet, 86073 Poitiers Cedex 9, France. b Department of Hospital Pharmacy, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. c Institut Lavoisier de Versailles, UMR CNRS 8180, Université de Versailles, 45 Avenue des Etats-Unis, 78035 Versailles Cedex, France.

Copies of 1H and 13C NMR spectra p 2-54

Cristallographic data for compound 10b p 55-59

Electronic Supplementary Material (ESI) for Organic & Biomolecular Chemistry.This journal is © The Royal Society of Chemistry 2019

Page 2: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

2

1H NMR spectrum (CDCl3, 400 MHz) of compound 2b.

Page 3: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

3

13C NMR spectrum (CDCl3, 100 MHz) of compound 2b.

Page 4: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

4

1H NMR spectrum (CDCl3, 400 MHz) of compound 4.

Page 5: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

5

13C NMR spectrum (CDCl3, 100 MHz) of compound 4.

Page 6: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

6

1H NMR spectrum (CDCl3, 400 MHz) of compound 7.

Page 7: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

7

13C NMR spectrum (CDCl3, 100 MHz) of compound 7.

Page 8: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

8

1H NMR spectrum (CDCl3, 400 MHz) of compound 8a.

Page 9: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

9

13C NMR spectrum (CDCl3, 100 MHz) of compound 8a.

Page 10: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

10

2D NOESY 1H NMR spectrum (CDCl3, 400 MHz) of compound 8a.

Page 11: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

11

1H NMR spectrum (Acetone-d6, 400 MHz) of compound 8b.

Page 12: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

12

13C NMR spectrum (Acetone-d6, 100 MHz) of compound 8b.

Page 13: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

13

1H NMR spectrum (CDCl3, 400 MHz) of compound 9a.

Page 14: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

14

13C NMR spectrum (CDCl3, 100 MHz) of compound 9a.

Page 15: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

15

1H NMR spectrum (CDCl3, 400 MHz) of compound 9b.

Page 16: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

16

13C NMR spectrum (CDCl3, 100 MHz) of compound 9b.

Page 17: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

17

1H NMR spectrum (Methanol-d4, 400 MHz) of compound 10a.

Page 18: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

18

13C NMR spectrum (Methanol-d4, 400 MHz) of compound 10a.

Page 19: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

19

1H NMR spectrum (Methanol-d4, 400 MHz) of compound 10b.

Page 20: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

20

13C NMR spectrum (Methanol-d4, 400 MHz) of compound 10b.

Page 21: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

21

1H NMR spectrum (Acetone-d6, 400 MHz) of compound 11a.

Page 22: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

22

13C NMR spectrum (Acetone-d6, 100 MHz) of compound 11a.

Page 23: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

23

2D NOESY 1H NMR spectrum (Acetone-d6, 100 MHz) of compound 11a.

Page 24: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

24

1H NMR spectrum (Acetone-d6, 400 MHz) of compound 11a’.

Page 25: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

25

13C NMR spectrum (Acetone-d6, 100 MHz) of compound 11a’.

Page 26: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

26

1H NMR spectrum (Methanol-d4, 400 MHz) of compound 12a.

Page 27: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

27

13C NMR spectrum (Methanol-d4, 400 MHz) of compound 12a.

Page 28: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

28

1H NMR spectrum (Methanol-d4, 400 MHz) of compound 12a’.

Page 29: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

29

13C NMR spectrum (Methanol-d4, 400 MHz) of compound 12a’.

Page 30: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

30

1H NMR spectrum (CDCl3, 400 MHz) of compound 11b.

Page 31: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

31

13C NMR spectrum (CDCl3, 400 MHz) of compound 11b.

Page 32: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

32

2D NOESY 1H NMR spectrum (CDCl3, 100 MHz) of compound 11b.

Page 33: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

33

1H NMR spectrum (CDCl3, 400 MHz) of compound 11b’.

Page 34: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

34

13C NMR spectrum (CDCl3, 400 MHz) of compound 11b’.

Page 35: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

35

1H NMR spectrum (Methanol-d4, 400 MHz) of compound 12b.

Page 36: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

36

13C NMR spectrum (Methanol-d4, 400 MHz) of compound 12b.

Page 37: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

37

1H NMR spectrum (Methanol-d4, 400 MHz) of compound 12b’.

Page 38: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

38

13C NMR spectrum (Methanol-d4, 400 MHz) of compound 12b’.

Page 39: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

39

1H NMR spectrum (CDCl3, 400 MHz) of compound 13a.

Page 40: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

40

13C NMR spectrum (CDCl3, 100 MHz) of compound 13a.

Page 41: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

41

1H NMR spectrum (CDCl3, 400 MHz) of compound 13b.

Page 42: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

42

13C NMR spectrum (CDCl3, 100 MHz) of compound 13b.

Page 43: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

43

1H NMR spectrum (CDCl3, 400 MHz) of compound 14a.

Page 44: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

44

13C NMR spectrum (CDCl3, 100 MHz) of compound 14a.

Page 45: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

45

1H NMR spectrum (CDCl3, 400 MHz) of compound 14b.

Page 46: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

46

13C NMR spectrum (CDCl3, 100 MHz) of compound 14b.

Page 47: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

47

1H NMR spectrum (Methanol-d4, 400 MHz) of compound 15a.

Page 48: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

48

13C NMR spectrum (Methanol-d4, 400 MHz) of compound 15a.

Page 49: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

49

1H NMR spectrum (Methanol-d4, 400 MHz) of compound 15b.

Page 50: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

50

13C NMR spectrum (Methanol-d4, 400 MHz) of compound 15b.

Page 51: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

51

1H NMR spectrum (CDCl3, 400 MHz) of compound 17.

Page 52: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

52

13C NMR spectrum (CDCl3, 100 MHz) of compound 17.

Page 53: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

53

1H NMR spectrum (CDCl3, 400 MHz) of compound 19.

Page 54: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

54

13C NMR spectrum (CDCl3, 100 MHz) of compound 19.

Page 55: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

55

Cristallographic data for compound 10b

CCDC 1921458

Page 56: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

56

Page 57: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

57

Page 58: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

58

Page 59: Electronic Supplementary Information · 1 Electronic Supplementary Information Synthesis and glycosidase inhibition of conformationally locked DNJ and DMJ derivatives exploiting a

59